(Reuters) - U.S. health regulators have accepted the application for Pfizer Inc's closely watched experimental rheumatoid arthritis drug, the drugmaker said on Tuesday. The Food and Drug Administration is due to decide on the drug, tofacitinib, in August. Pfizer said it has also submitted an application for tofacitinib to regulatory authorities in Japan. Tofacitinib is one of Pfizer's most ...

Arthritis-treatment developer Horizon Pharma Inc. said Tuesday that the Food and Drug Administration has accepted its application for the rheumatoid arthritis treatment Lodotra and plans to make a decision on the drug by July 26.

Arthritis-treatment developer Horizon Pharma Inc. said Tuesday that the Food and Drug Administration has accepted its application for the rheumatoid arthritis treatment Lodotra and plans to make a decision on the drug by July 26.

Roche Holding AG ’s Actemra medicine won expanded U.S. approval as a treatment for moderate to severe rheumatoid arthritis.

ATLANTA, Nov. 2, 2010 /PRNewswire-USNewswire/ -- Arthritis Foundation patient advocate, Jan Wyatt, PhD, will provide oral testimony on behalf of the approximately 4 million Americans with inflammatory arthritis at a Food and Drug Administration (FDA) hearing today. The hearing will focus on issues and challenges associated with an approval pathway for biologic products that are highly similar ...